½ÃÀ庸°í¼­
»óǰÄÚµå
1455684

À̽ÄÇü Á¦¼¼µ¿±â(ICD) ½ÃÀå : Á¦Ç° À¯Çüº°, ÀåÄ¡ À¯Çüº°, NYHA Ŭ·¡½º À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)

Implantable Cardioverter Defibrillators Market, By Product Type, By Device type, By NYHA Class Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: AnalystView Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® 284 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

À̽ÄÇü Á¦¼¼µ¿±â(ICD) ½ÃÀå ±Ô¸ð´Â 2023³â 39¾ï 4,556¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 7.41% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ICD ½ÃÀå - ½ÃÀå ¿ªÇÐ

±â¼ú ¹ßÀü°ú Á¦Ç° Çõ½ÅÀº ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÕ´Ï´Ù.

MedtronicÀÇ Epsila EV MRI SureScan ¹× Aurora Extravascular(EV)-ICD MRI SureScan°ú °°Àº ±â¼ú ¹ßÀü°ú Á¦Ç° ¹ß¸íÀº ÇÕº´Áõ °¨¼Ò ¹× ¼³Ä¡ ±â¼ú °³¼±°ú °°Àº À¯¸ÁÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÇöÀç ÁøÇà ÁßÀÎ ±â¼ú ¹ßÀü, ƯÈ÷ ÃÖ±Ù ¸î ³âµ¿¾È ¸ñ°ÝµÈ ICDÀÇ ³î¶ó¿î ¼º°ø·üÀº ½ÃÀåÀÇ Ãß°¡ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 8¿ù, ¸ÞµåÆ®·Î´Ð PLC´Â °©ÀÛ½º·± ½ÉÀ帶ºñ¸¦ ¿¹¹æÇϱâ À§ÇÑ Çõ½ÅÀûÀÎ Àúħ½ÀÀû Á¦¼¼µ¿±â ÀÓÇöõÆ®ÀÎ ¸ÞµåÆ®·Î´Ð EV ICD ½Ã½ºÅÛÀÇ È¿´ÉÀ» ÀÔÁõÇÏ´Â Àӻ󿬱¸¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Ç÷°ü¿Ü ICD ½Ã½ºÅÛÀº ÁÖ¿ä ±¸¼º¿ä¼Ò¸¦ ¿ÞÂÊ °Üµå¶ûÀÌ ¾Æ·¡¿¡ ¹èÄ¡Çϰí Ȧµå¾÷ ÆäÀÌ½Ì ¿ä¹ýÀ» ÅëÇØ Áøµ¿À» ¾ïÁ¦ÇÏ°í ºó¸ÆÀ» ¿¹¹æÇϸç Á¦¼¼µ¿ ¼îÅ©¸¦ ÇÇÇÒ ¼ö ÀÖµµ·Ï ȯÀÚ¸¦ µ½½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí À§ÇèÀ» ÁÙÀÌ¸ç ½ÉÀå Ä¡·á ±â¼ú ¹ßÀü¿¡ ´ëÇÑ ¾÷°èÀÇ ³ë·ÂÀ» °­Á¶ÇÔÀ¸·Î½á ½ÃÀå¿¡ Å« ±â¿©¸¦ Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ½Ã¼³¿¡¼­ ICDÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå È®´ëÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 12¿ù Ŭ¸®ºí·£µå Ŭ¸®´Ð(Cleveland Clinic)Àº ±¹Á¦ ÀÓ»ó½ÃÇèÀÇ ÀÏȯÀ¸·Î ¼¼°è ÃÖÃÊ·Î µÎ ¸íÀÇ È¯ÀÚ¿¡°Ô ¹«½ÉÀå Á¦¼¼µ¿±â ½Ã½ºÅÛÀ» ¼º°øÀûÀ¸·Î À̽ÄÇÏ´Â µ¥ ¼º°øÇß½À´Ï´Ù. ±× °á°ú, ÀÌ Áö¿ª¿¡¼­ ICDÀÇ º¸±Þ°ú ½ÉÀå ¸®µë Àå¾ÖÀÇ À¯º´·ü Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ICD ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032) µ¿¾È ¸Å³â ¾à 7.41%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â °æÁ¤¸Æ ICD°¡ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±â±â À¯Çüº°·Î´Â 2023³â ¾ç½É½Ç ±â±â°¡ ÁÖ¿ä À¯ÇüÀ¸·Î ºÎ»óÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

NYHA Ŭ·¡½ºº°·Î´Â 2023³â NYHA Ŭ·¡½º II°¡ ÁÖ¿ä À¯ÇüÀ¸·Î ºÎ»óÇÒ °ÍÀÔ´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¸ÅÃâ 1À§

À̽ÄÇü Á¦¼¼µ¿±â ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

ICD ¼¼°è ½ÃÀåÀº Á¦Ç° À¯Çü, ÀåÄ¡ À¯Çü, NYHA Ŭ·¡½º À¯Çü, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó °æÁ¤¸Æ ICD(T-ICD)¿Í ÇÇÇÏ ICD ºÎ¹®(S-ICD)·Î ºÐ·ùµÇ¸ç, 2023³â¿¡´Â T-ICD ºÎ¹®ÀÌ ½ÃÀå¿¡¼­ Áö¹èÀûÀÎ À§Ä¡¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§´Â T-ICD°¡ »ý¸íÀ» À§ÇùÇÏ´Â ½É½Ç ºÎÁ¤¸ÆÀ» °ü¸®Çϰí ħ½ÀÀû ¼ö¼ú°ú °ü·ÃµÈ ÇÕº´Áõ ¹× ÀÇ·á ºñ¿ëÀ» ÁÙÀÌ´Â µ¥ ÀÖ¾î ±ÍÁßÇÑ ÀÌÁ¡À» Á¦°øÇϱ⠶§¹®À̸ç, T-ICD´Â ¿µ±¸ ¹Úµ¿, ½ÉÀå À絿±âÈ­ Ä¡·á(CRT), Ç×ºó¸Æ ¹Úµ¿°ú °°Àº ±â´ÉÀ» ÅëÇØ ½É½Ç¼¼µ¿(VF) ¹× ½É½Ç¼¼µ¿(VF) ¹× ½É½Çºó¸Æ(VT) ȯÀÚÀÇ ¿ä±¸¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀº ÀåÄ¡ À¯Çü¿¡ µû¶ó ´ÜÀÏ Ã¨¹ö ICD, ÀÌÁß Ã¨¹ö ICD, ¾ç½É½Ç ÀåÄ¡ µî ¼¼ °¡Áö·Î ºÐ·ùµÇ¸ç, 2023³â¿¡´Â ¾ç½É½Ç ÀåÄ¡ ºÎ¹®ÀÌ ½ÃÀå ¸®´õ·Î ºÎ»óÇß½À´Ï´Ù. ½ÉÀå µ¹¿¬»ç Áõ°¡, ½É¹ÚÁ¶À²±â¿Í Á¦¼¼µ¿±â·Î¼­ÀÇ ÀÌÁß ±â´É µîÀÇ ¿äÀÎÀÌ CRT-D ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯ÇØÇÑ »óŸ¦ ½Å¼ÓÇÏ°Ô º¸°íÇÏ´Â ±â´É°ú Çâ»óµÈ ÆäÀÌ½Ì ¼º´ÉÀÌ °áÇÕµÇ¾î »ç¸Á·ü °¨¼Ò¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷µéÀº ÀÌ·¯ÇÑ ÀåÄ¡¸¦ °­È­ÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2019³â 3¿ù ¹ÙÀÌ¿ÀÆ®·Î´Ð(BIOTRONIK)Àº À¯·´ ½ÃÀå¿¡¼­ ¼¼°è¿¡¼­ °¡Àå ÀÛÀº CRT-D ¹× ICD ÀåÄ¡¸¦ Ãâ½ÃÇßÀ¸¸ç, 3Å×½½¶ó Àü½Å MRI ½ºÄµ ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. ¶ÇÇÑ MRI ȣȯ¼º, ºí·çÅõ½º ±â´É, 4±Ø ¸®µå µî ÀÌ ºÎ¹®ÀÇ ±â¼ú ¹ßÀüÀº äÅ÷üÀ» ³ôÀÏ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 7¿ù Abbott´Â Â÷¼¼´ë ºí·çÅõ½º Áö¿ø CRT-D ¹× ICD¿¡ ´ëÇÑ FDA ½ÂÀÎÀ» ¹ßÇ¥Çß½À´Ï´Ù.

ICD ½ÃÀå - Áö¸®Àû ÅëÂû·Â

Áö¿ªÀûÀ¸·Î´Â ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªµéÀº ºñÁî´Ï½º¸¦ °¡Á®¿À´Â ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µË´Ï´Ù.

ICD ½ÃÀå - °æÀï ±¸µµ :

ICD ½ÃÀå¿¡ ÁøÃâÇÑ ±â¾÷µéÀº Á¦Ç°À» °­È­Çϱâ À§ÇØ ´Ù¾çÇÑ Àü·«À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àü·«¿¡´Â ÃÖ¼Ò Ä§½ÀÀû ½Ã¼úÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ¼ÒÇüÈ­, ¹èÅ͸® ¼ö¸í ¿¬Àå µî ±â±âÀÇ È¿°ú¿Í ȯÀÚ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇÑ ±â¼ú ¹ßÀüÀÌ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ, °¢ ¾÷üµéÀº ´Éµ¿ÀûÀΠȯÀÚ °ü¸®¿Í µ¥ÀÌÅÍ ±â¹Ý ÀÇ»ç°áÁ¤À» ÃËÁøÇϱâ À§ÇØ ¿ø°Ý ¸ð´ÏÅ͸µ ±â´ÉÀ» °®Ãá Áö´ÉÇü ±â±â °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á Á¦°ø¾÷ü ¹× ¿¬±¸ ±â°ü°úÀÇ Çù¾÷Àº Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÃֽŠÀÇ·á ¹ßÀüÀ» ÅëÇÕÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¶ÇÇÑ, ±ÔÁ¦ Áؼö¿Í ¾ö°ÝÇÑ Ç°Áú ±âÁØ Áؼö¸¦ À§ÇÑ ³ë·ÂÀº ¼ÒºñÀÚÀÇ ½Å·Ú¸¦ °­È­ÇÏ°í ½ÃÀå ħÅõ¸¦ ÃËÁøÇÏ¿©À̽ÄÇü Á¦¼¼µ¿±â(ICD) ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå À̽ÄÇü Á¦¼¼µ¿±â(ICD) ½ÃÀå °³¿ä

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ÃßÁ¤ ¿¬µµ

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ³»¿ª
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå ICD ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ÇâÈÄ ½ÃÀå µ¿Çâ

Á¦4Àå ICD ¾÷°è Á¶»ç

  • PEST ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ±ÔÁ¦ ±¸Á¶ ºÐ¼®

Á¦5Àå À̽ÄÇü Á¦¼¼µ¿±â(ICD) ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

  • COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
  • COVID-19 ÀÌÈÄÀÇ ¿µÇ⠺м®

Á¦6Àå À̽ÄÇü Á¦¼¼µ¿±â(ICD) ½ÃÀå ±¸µµ

  • ICD ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • ÁÖ¿ä Á¦Á¶¾÷üº° ºÐ¼® µ¥ÀÌÅÍ
    • ±âÁ¸ ±â¾÷ ºÐ¼®
    • ½Å±Ô ±â¾÷ ºÐ¼®

Á¦7Àå À̽ÄÇü Á¦¼¼µ¿±â(ICD) ½ÃÀå - Á¦Ç° À¯Çüº°

  • °³¿ä
    • Á¦Ç° À¯Çüº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • °æÁ¤¸Æ ICD
    • ÇÇÇÏ ICD

Á¦8Àå À̽ÄÇü Á¦¼¼µ¿±â(ICD) ½ÃÀå - µð¹ÙÀ̽º À¯Çüº°

  • °³¿ä
    • µð¹ÙÀ̽º À¯Çüº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ½Ì±Û è¹ö ICD
    • µà¾ó è¹ö ICD
    • ¾ç½É½Ç µð¹ÙÀ̽º

Á¦9Àå À̽ÄÇü Á¦¼¼µ¿±â(ICD) ½ÃÀå - NYHA Ŭ·¡½º ŸÀÔº°

  • °³¿ä
    • NYHA Ŭ·¡½º ŸÀÔº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • NYHA Ŭ·¡½º II
    • NYHA Ŭ·¡½º III

Á¦10Àå À̽ÄÇü Á¦¼¼µ¿±â(ICD) ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä
    • ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • º´¿ø
    • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • ±âŸ

Á¦11Àå À̽ÄÇü Á¦¼¼µ¿±â(ICD) ½ÃÀå - Áö¿ªº°

  • ¼­·Ð
  • ºÏ¹Ì
    • °³¿ä
    • ºÏ¹Ì ÁÖ¿ä Á¦Á¶¾÷ü
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • °³¿ä
    • À¯·´ ÁÖ¿ä Á¦Á¶¾÷ü
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ·¯½Ã¾Æ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • Æú¶õµå
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
    • °³¿ä
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ÁÖ¿ä Á¦Á¶¾÷ü
    • Àεµ
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • Àεµ³×½Ã¾Æ
    • Çʸ®ÇÉ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • °³¿ä
    • ¶óƾ¾Æ¸Þ¸®Ä« ÁÖ¿ä Á¦Á¶¾÷ü
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • °³¿ä
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÁÖ¿ä Á¦Á¶¾÷ü
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ÅÍŰ
    • ¾ËÁ¦¸®
    • ÀÌÁýÆ®
    • ±âŸ

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® - ICD ¾÷°è

  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä
    • Abbott
    • Medtronic
    • BIOTRONIK SE &Co. KG
    • Boston Scientific Corporation
    • MicroPort Scientific Corporation.
    • LivaNova PLC.
    • Others

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

LSH 24.05.02

REPORT HIGHLIGHT

Implantable cardioverter defibrillators Market size was valued at USD 3,945.56 Million in 2023, expanding at a CAGR of 7.41% from 2024 to 2032.

The implantable cardioverter defibrillator (ICD) is an electronic medical device utilized for monitoring and controlling heart rhythms in individuals vulnerable to life-threatening arrhythmias like ventricular tachycardia as well as ventricular fibrillation. Market growth drivers encompass technological advancements, increasing occurrences of sudden cardiac arrest, rising public awareness, and supportive governmental and healthcare organizational policies. Emerging players' innovation efforts, exemplified by MicroPort Scientific Corporation's receipt of a CE mark for its INVICTA line of defibrillation leads in July 2022, also contribute to market expansion. With the escalating prevalence of cardiovascular diseases (CVDs), the demand for advanced cardiac care solutions, including ICDs, is anticipated to surge, presenting opportunities for healthcare sector expansion and advancements.

Implantable cardioverter defibrillators Market- Market Dynamics

Technological progress and product innovations to propel market demand

Technological progress and product inventions, including Medtronic's Epsila EV MRI SureScan along with Aurora Extravascular (EV)-ICD MRI SureScan, offer promising solutions with reduced complications and improved placement techniques. The ongoing technological advancements, particularly the commendable success rates witnessed in recent years for ICDs, are expected to propel further market growth. For instance, in August 2022, Medtronic PLC presented clinical research demonstrating the efficacy of an innovative minimally invasive defibrillator implant, the Medtronic EV ICD system, aimed at preventing sudden cardiac arrest. This extravascular implantable defibrillator scheme, with its main component located beneath the left armpit, delivers holdup pacing therapy to reduce vibrations, prevent tachycardia, and assist patients in avoiding defibrillation shock. Such advancements significantly contribute to the market by enhancing patient outcomes, mitigating risks, and highlighting the industry's commitment to advancing cardiac care technologies. Moreover, the increasing adoption of ICDs within healthcare facilities is poised to be a significant market expansion driver. For instance, in December 2021, Cleveland Clinic successfully conducted leadless pacemaker defibrillator system implants in the first two patients globally as part of an international clinical trial. This innovative device, designed to address both low and elevated heart rates, integrates leadless pacemaker End User with subcutaneous ICDs. Consequently, the growing acceptance of implantable defibrillators and the rising prevalence of cardiac rhythm disorders in the region are expected to drive market growth.

Implantable cardioverter defibrillators Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.41% over the forecast period (2024-2032)

Based on product type segmentation, transvenous implantable cardioverter-defibrillators was predicted to show maximum market share in the year 2023

Based on Device type segmentation, biventricular devices was the leading type in 2023

Based on NYHA Class Type segmentation, NYHA Class II was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Implantable cardioverter defibrillators Market- Segmentation Analysis:

The Global Implantable cardioverter defibrillators Market is segmented on the basis of Product Type, Device type, NYHA Class Type, End User, and Region.

The market is divided into two categories based on product type: transvenous implantable cardioverter-defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillator segments (S-ICDs) based on product type. In 2023, the T-ICDs segment held the dominant position in the market. This dominance is attributed to the valuable advantages offered by T-ICDs in managing life-threatening ventricular arrhythmias, as well as in reducing procedural complications and medical costs associated with invasive surgeries. T-ICDs cater to the needs of patients with ventricular fibrillation (VF) and ventricular tachycardia (VT) through features like permanent pacing, cardiac resynchronization therapy (CRT), and anti-tachycardia pacing.

The market is divided into three categories based on Device type: single-chamber ICDs, dual-chamber ICDs, and biventricular devices. In 2023, the biventricular devices segment emerged as the market leader. Factors such as the increasing prevalence of sudden cardiac deaths and its dual functionality as a pacemaker and a defibrillator are anticipated to drive the demand for CRT-D devices. The ability to promptly report adverse conditions, combined with enhanced pacing performance, contributes to reducing mortality rates. Moreover, major players are concentrating on enhancing these devices. For instance, in March 2019, BIOTRONIK introduced the smallest CRT-D and ICD devices globally in the European market, which were approved for 3 Tesla full-body MRI scans. Additionally, technological advancements in this segment, such as MRI compatibility, Bluetooth capability, and quadripolar leads, have the potential to enhance adoption rates. For example, in July 2020, Abbott announced FDA approval for its next-generation Bluetooth-enabled CRT-D and ICD devices.

Implantable cardioverter defibrillators Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Implantable cardioverter defibrillators Market- Competitive Landscape:

Companies operating in the implantable cardioverter defibrillators (ICD) market are employing various strategies to enhance their offerings. These strategies encompass technological advancements aimed at improving device efficacy and patient outcomes, such as miniaturization to enable less invasive procedures and prolonging battery life. Furthermore, companies are concentrating on the development of intelligent devices equipped with remote monitoring capabilities to facilitate proactive patient management and data-driven decision-making. Collaborations with healthcare providers and research institutions play a pivotal role in fostering continuous innovation and ensuring the integration of the latest medical advancements. Additionally, efforts directed towards regulatory compliance and adherence to stringent quality standards serve to reinforce consumer trust and enhance market penetration, thereby fostering sustained growth in the ICD market.

Recent Developments:

In June 2023, BIOTRONIK SE & Co. KG entered into a partnership with Royal Philips aimed at expanding the latter's admission to cardiovascular devices. Philips SymphonySuite, the primary entity solution available for cardiovascular care in Ambulatory Surgery Centers (ASCs) and office-based labs, stands as a testament to this collaborative effort.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott

Medtronic

BIOTRONIK SE & Co. KG

Boston Scientific Corporation

MicroPort Scientific Corporation.

LivaNova PLC.

Others

GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Transvenous Implantable Cardioverter-Defibrillators
  • Subcutaneous Implantable Cardioverter Defibrillators

GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY DEVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Single Chamber ICDs
  • Dual Chamber ICDs
  • Biventricular Devices

GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY NYHA CLASS TYPE- MARKET ANALYSIS, 2019 - 2032

  • NYHA Class II
  • NYHA Class III

GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Implantable cardioverter defibrillators Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Implantable cardioverter defibrillators Market Snippet by Product Type
    • 2.1.2.Implantable cardioverter defibrillators Market Snippet by Device Type
    • 2.1.3.Implantable cardioverter defibrillators Market Snippet by NYHA Class Type
    • 2.1.4.Implantable cardioverter defibrillators Market Snippet by End Use
    • 2.1.5.Implantable cardioverter defibrillators Market Snippet by Country
    • 2.1.6.Implantable cardioverter defibrillators Market Snippet by Region
  • 2.2.Competitive Insights

3.Implantable cardioverter defibrillators Key Market Trends

  • 3.1.Implantable cardioverter defibrillators Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Implantable cardioverter defibrillators Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Implantable cardioverter defibrillators Market Opportunities
  • 3.4.Implantable cardioverter defibrillators Market Future Trends

4.Implantable cardioverter defibrillators Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Implantable cardioverter defibrillators Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Implantable cardioverter defibrillators Market Landscape

  • 6.1.Implantable cardioverter defibrillators Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Implantable cardioverter defibrillators Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Transvenous Implantable Cardioverter-Defibrillators
    • 7.1.3.Subcutaneous Implantable Cardioverter Defibrillators

8.Implantable cardioverter defibrillators Market - By Device Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Device Type, 2023 & 2032 (%)
    • 8.1.2.Single Chamber ICDs
    • 8.1.3.Dual Chamber ICDs
    • 8.1.4.Biventricular Devices

9.Implantable cardioverter defibrillators Market - By NYHA Class Type

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By NYHA Class Type, 2023 & 2032 (%)
    • 9.1.2.NYHA Class II
    • 9.1.3.NYHA Class III

10.Implantable cardioverter defibrillators Market - By End Use

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 10.1.2.Hospitals
    • 10.1.3.Ambulatory Surgical Centers
    • 10.1.4.Others

11.Implantable cardioverter defibrillators Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Implantable cardioverter defibrillators Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Implantable cardioverter defibrillators Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Implantable cardioverter defibrillators Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Implantable cardioverter defibrillators Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Implantable cardioverter defibrillators Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Implantable cardioverter defibrillators Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Abbott
    • 12.2.2.Medtronic
    • 12.2.3.BIOTRONIK SE & Co. KG
    • 12.2.4.Boston Scientific Corporation
    • 12.2.5.MicroPort Scientific Corporation.
    • 12.2.6.LivaNova PLC.
    • 12.2.7.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦